Breastfeeding and obesity among Kuwaiti preschool children

N Al-Qaoud1, P Prakash

  • 1Administration of Food and Nutrition, Ministry of Health, Shuwaikh 70655, Kuwait. alqaoudnawal@yahoo.com

Insights

Breastfeeding does not appear to reduce obesity risk in Kuwaiti preschoolers. However, maternal obesity significantly increases a child's risk of being overweight or obese.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Childhood Obesity Research

Background:

  • Childhood obesity is a growing global concern.
  • Understanding risk factors for pediatric obesity is crucial for developing effective prevention strategies.
  • The role of breastfeeding in long-term weight status requires further investigation in diverse populations.

Purpose of the Study:

  • To investigate the association between breastfeeding and its duration with the risk of overweight and obesity in Kuwaiti preschool children.
  • To identify other significant predictors of obesity in this population.

Main Methods:

  • A cross-sectional study involving 2,291 preschool children (3-6 years) and their mothers in Kuwait.
  • Data collected via questionnaires and anthropometric measurements (height and weight) from September 2003 to June 2004.
  • Statistical analysis adjusted for potential confounding factors.

Main Results:

  • No significant association was found between breastfeeding or its duration and overweight/obesity in preschool children.
  • Significant predictors of childhood obesity included child's gender (girls at higher risk), age (4-5 years at higher risk), and higher birth weight.
  • Maternal obesity was a strong predictor, with children of obese mothers having a significantly higher risk of being overweight or obese.

Conclusions:

  • Breastfeeding and its duration were not associated with obesity status in Kuwaiti preschoolers.
  • A strong positive association exists between maternal obesity and child obesity.
  • Child's gender, age, and birth weight are significant factors influencing weight status in early childhood.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...